Certified by Founder
Lodge
Edgewood Oncology
start up
United States
- Boston, Massachusetts
- 26/03/2024
- Series A
- $20,000,000
Synergistically targeting the master regulators of cancer
- Industry Biotechnology Research
- Website https://www.edgewoodoncology.com/
- LinkedIn https://www.linkedin.com/company/edgewood-oncology/
Related People
David CookFounder
United States -
Boston, Massachusetts
Accomplished senior executive and developer of biotechnology products. Experienced with microbiome therapeutics, vaccines, small molecules, and biologics. Involved in all aspects of product development including discovery research, clinical trials, regulatory affairs, manufacturing, business development, intellectual property and corporate operations. Directly responsible for obtaining the EU marketing authorization for four novel medical products.
Specialties: Microbiome, Infectious Disease, Vaccines and Immunotherapy, Inflammation and Immunology, Immuno-oncology
OpenRouter | $113,000,000 | (May 27, 2026)
The Path | $14,300,000 | (May 27, 2026)
Quartermaster | $43,000,000 | (May 27, 2026)
Qurie GmbH | $2,560,151 | (May 27, 2026)
Clouted | $7,000,000 | (May 27, 2026)
ClearOps | $10,009,454 | (May 27, 2026)
Hardline | $2,000,000 | (May 27, 2026)
Squid | $6,000,000 | (May 27, 2026)
Hark(1) | $700,000,000 | (May 22, 2026)
Dandelion Health | $14,000,000 | (May 22, 2026)
Century Health | $5,000,000 | (May 22, 2026)
shatterdome energy | $3,500,000 | (May 22, 2026)